Objectives: To document current percutaneous liver biopsy (PLB) practices among pediatric gastroenterologists.
Materials And Methods: A total of 699 practicing pediatric gastroenterologists received an e-mail invitation to participate in a Web-based survey. Our primary outcome was whether or not pediatric gastroenterologists reported currently performing PLB. We queried a number of practice preferences and potential factors that affect preferences among all of the participants.
Results: Of 474 participants who opened the e-mail, 317 (67%) completed the survey. Of those, 35% said that they performed no PLBs in an average month, instead referring patients who require the procedure to interventional radiologists. Patient safety and desire for ultrasound guidance were rated the most important reasons for referral. Adjusted analysis showed that pediatric gastroenterologists in academic settings were twice as likely to report performing PLB as those practicing elsewhere (P = .003). The interval since fellowship training was not associated with PLB performance in crude or adjusted analyses. Among those participants who did report performing PLB, substantial variation was found in preferred biopsy device, use of ultrasound assistance, and routine hospital admission post-PLB. No practice preferences were found to be associated with routine admission.
Conclusions: Many pediatric gastroenterologists report systematically and rationally referring children to interventional radiologists for PLB, rather than performing the procedure themselves. Crude numbers suggest that many who do not perform PLB are in academic practice settings, where fellowship training is presumably affected. Those pediatric gastroenterologists who do report performing PLB vary greatly in their preprocedure, patient disposition, and postprocedure routines.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/MPG.0b013e318053eab4 | DOI Listing |
J Clin Med
January 2025
Department of Pathology, Ghent University Hospital, Ghent University, 9000 Ghent, Belgium.
: Gastrointestinal diseases are a major cause of morbidity in common variable immunodeficiency disorder (CVID), clinically often mimicking other conditions including celiac disease and inflammatory bowel disease (IBD). Hence, diagnosis of CVID remains challenging. This study aims to raise awareness and highlight histopathological clues for CVID in intestinal biopsies, emphasizing diagnostic pitfalls for the pathologist/gastroenterologist.
View Article and Find Full Text PDFUnited European Gastroenterol J
January 2025
Sheba Medical Center, Institute of Gastroenterology, Ramat-Gan, Israel.
Background: The Montreal classification has been widely used in Crohn's disease since 2005 to categorize patients by the age of onset (A), disease location (L), behavior (B), and upper gastrointestinal tract and perianal involvement. With evolving management paradigms in Crohn's disease, we aimed to assess the performance of gastroenterologists in applying the Montreal classification.
Methods: An online survey was conducted among participants at an international educational conference on inflammatory bowel diseases.
Turk J Pediatr
December 2024
Gastroenterology Division, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Background: Understanding the outcome of functional constipation (FC) for both patients and physicians is essential, yet it has been infrequently reported worldwide. The objective of this report was to update the outcomes of FC in Saudi children.
Methods: Clinical data including age, sex, response to management, duration of follow up, and type of management were collected from the notes of each clinic visits and phone call follow-ups.
Clin Gastroenterol Hepatol
January 2025
Inflammatory Bowel Disease Center, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville FL. Electronic address:
Description: The aim of this American Gastroenterological Association (AGA) Clinical Practice Update (CPU) is to provide best practice advice (BPA) statements for gastroenterologists and other health care providers who provide care to patients with inflammatory bowel disease (IBD). The focus is on IBD-specific screenings (excluding colorectal cancer screening, which is discussed separately) and vaccinations. We provide guidance to ensure that patients are up to date with the disease-specific cancer screenings, vaccinations, as well as advice for mental health and general wellbeing.
View Article and Find Full Text PDFInn Med (Heidelb)
January 2025
Dr. von Haunersches Kinderspital, Kinderklinik und Kinderpoliklinik, Ludwig-Maximilians-Universität München, Lindwurmstr. 4, 80337, München, Deutschland.
Pediatric-onset inflammatory bowel disease (PIBD) is increasingly recognized in Germany. Patients with PIBD often present with more extensive and active disease. Clinical suspicion of IBD requires early initiation of the diagnostic work-up (e.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!